loading

Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
12.95%
220.50
195.21 224.93 234.21 568.44
Nonoperating Income/Loss
17.14%
4.796
5.788 5.753 2.418 2.729
Net Income/Loss
13.87%
-215.70
-189.42 -219.17 -231.79 -565.71
Basic Average Shares
0.35%
778.18
775.46 6.3137 743.42 742.62
Diluted Average Shares
0.35%
778.18
775.46 6.3137 743.42 742.62
Basic Earnings Per Share
16.67%
-0.28
-0.24 -0.28 -0.31 -0.76
Diluted Earnings Per Share
16.67%
-0.28
-0.24 -0.28 -0.31 -0.76
$218.42
price down icon 1.81%
$59.86
price up icon 1.42%
$121.19
price up icon 2.24%
$229.23
price up icon 2.94%
$65.35
price up icon 0.48%
$110.42
price up icon 0.53%
Kapitalisierung:     |  Volumen (24h):